JP2016529306A5 - - Google Patents

Download PDF

Info

Publication number
JP2016529306A5
JP2016529306A5 JP2016539571A JP2016539571A JP2016529306A5 JP 2016529306 A5 JP2016529306 A5 JP 2016529306A5 JP 2016539571 A JP2016539571 A JP 2016539571A JP 2016539571 A JP2016539571 A JP 2016539571A JP 2016529306 A5 JP2016529306 A5 JP 2016529306A5
Authority
JP
Japan
Prior art keywords
alkyl
cyano
hydroxyl
disease
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016539571A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016529306A (ja
JP6408008B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2014/069088 external-priority patent/WO2015032945A1/en
Publication of JP2016529306A publication Critical patent/JP2016529306A/ja
Publication of JP2016529306A5 publication Critical patent/JP2016529306A5/ja
Application granted granted Critical
Publication of JP6408008B2 publication Critical patent/JP6408008B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016539571A 2013-09-09 2014-09-08 ジペプチジルペプチダーゼiインヒビターとしてのペプチジルニトリル化合物 Active JP6408008B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP13183519.1 2013-09-09
EP13183519 2013-09-09
EP14151979 2014-01-21
EP14151979.3 2014-01-21
PCT/EP2014/069088 WO2015032945A1 (en) 2013-09-09 2014-09-08 Peptidyl nitril compounds as dipeptidyl peptidase i inhibitors

Publications (3)

Publication Number Publication Date
JP2016529306A JP2016529306A (ja) 2016-09-23
JP2016529306A5 true JP2016529306A5 (enExample) 2017-10-12
JP6408008B2 JP6408008B2 (ja) 2018-10-17

Family

ID=51535425

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016539571A Active JP6408008B2 (ja) 2013-09-09 2014-09-08 ジペプチジルペプチダーゼiインヒビターとしてのペプチジルニトリル化合物

Country Status (10)

Country Link
US (1) US9856228B2 (enExample)
EP (1) EP3044214B1 (enExample)
JP (1) JP6408008B2 (enExample)
CN (1) CN105612149A (enExample)
AU (1) AU2014317048B2 (enExample)
CA (1) CA2923484C (enExample)
DK (1) DK3044214T3 (enExample)
EA (1) EA029030B1 (enExample)
SG (1) SG11201601150WA (enExample)
WO (2) WO2015032945A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3044214T3 (da) 2013-09-09 2017-11-13 Prozymex As Peptidylnitrilforbindelser som dipeptidylpeptidase-I-inhibitorer
NO2699580T3 (enExample) 2014-01-24 2018-02-24
DK3265452T3 (en) * 2015-03-05 2020-06-08 Neuprozyme Therapeutics ApS Peptidyl nitril compounds as dipeptidyl peptidase i inhibitors
CN107690429B (zh) 2015-04-07 2022-02-25 Ela制药有限公司 用于治疗和/或预防细胞或组织坏死的组合物,其特异性靶向组织蛋白酶c和/或cela1和/或cela3a和/或与其结构相关的酶
FI3758708T3 (fi) 2018-03-01 2025-02-18 Astrazeneca Ab (2s)-{(1s)-1-syano-2-[4-(3-metyyli-2-okso-2,3-dihydro-1,3-bentsoksatsol-5-yyli)fenyyli]etyyli}-1,4-oksatsepaani-2-karboksamidia käsittäviä farmaseuttisia koostumuksia
KR20210032431A (ko) 2018-07-17 2021-03-24 인스메드 인코포레이티드 루푸스 신염을 치료하기 위한 특정 (2s)-n-[(1s)-1-시아노-2-페닐에틸]-1,4-옥사제판-2-카복스아미드
CA3181285A1 (en) 2020-07-20 2022-01-27 Jessica BASSO Methods for extracting neutrophil serine proteases and treating dipeptidyl peptidase 1-mediated conditions
IL317570A (en) 2022-06-13 2025-02-01 Alivexis Inc Azacycloalkylcarbonyl cyclic amines and their use
EP4646265A1 (en) 2023-01-06 2025-11-12 Insmed Incorporated Novel, reversible dpp1 inhibitors and uses thereof
WO2025162472A1 (en) * 2024-01-31 2025-08-07 Insmed Incorporated Linear dipeptidyl peptidase 1 inhibitors and uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20100098683A (ko) * 2007-12-12 2010-09-08 아스트라제네카 아베 펩티딜 니트릴, 및 디펩티딜 펩티다제 i 억제제로서의 그의 용도
KR100903499B1 (ko) 2007-12-27 2009-06-18 엔에이치엔비즈니스플랫폼 주식회사 검색 의도 분류에 따른 광고 제공 방법 및 상기 방법을수행하기 위한 시스템
AU2010244218B2 (en) * 2009-05-07 2012-07-19 Astrazeneca Ab Substituted 1-cyanoethylheterocyclylcarboxamide compounds 750
WO2010142985A1 (en) 2009-06-10 2010-12-16 Astrazeneca Ab Substituted n-[1-cyano-2-(phenyl)ethyl]piperidin-2-ylcarboxmide compounds 761
WO2011154677A1 (en) 2010-06-09 2011-12-15 Astrazeneca Ab Substituted n-[1-cyano-2-(phenyl)ethyl] 1-aminocycloalk-1-ylcarboxamide compounds - 760
WO2012119941A1 (en) * 2011-03-04 2012-09-13 Prozymex A/S Peptidyl nitrilcompounds as peptidase inhibitors
WO2012130299A1 (en) 2011-03-30 2012-10-04 Prozymex A/S Peptidase inhibitors
US8999975B2 (en) * 2011-09-19 2015-04-07 Boehringer Ingelheim International Gmbh Substituted N- [1-cyano-2- (phenyl) ethyl] -2-azabicyclo [2.2.1] heptane-3-carboxamide inhibitors of cathepsin C
DK3044214T3 (da) 2013-09-09 2017-11-13 Prozymex As Peptidylnitrilforbindelser som dipeptidylpeptidase-I-inhibitorer

Similar Documents

Publication Publication Date Title
JP2018507223A5 (enExample)
JP2018535967A5 (enExample)
JP2019524883A5 (enExample)
JP2018534348A5 (enExample)
JP2016525130A5 (enExample)
JP2017523225A5 (enExample)
JP2014097964A5 (enExample)
JP2010530897A5 (enExample)
JP2014511891A5 (enExample)
JP2017530959A5 (enExample)
JP2018510139A5 (enExample)
JP2015508103A5 (enExample)
JP2016510326A5 (enExample)
JP2016500111A5 (enExample)
JP2020532547A5 (enExample)
JP2010524932A5 (enExample)
JP2015024998A5 (enExample)
JP2014515351A5 (enExample)
JP2011037841A5 (enExample)
JP2014528403A5 (enExample)
FI3562487T3 (fi) Metalloentsyymi-inhibiittoriyhdisteitä
JP2017514910A5 (enExample)
JP2016511753A5 (enExample)
JP2018538273A5 (enExample)
JP2017529389A5 (enExample)